Abstract
BackgroundNatural killer (NK) cells are being leveraged in the clinic due to their safety profile and their ability to mediate tumor killing without prior priming. However, lack of antigen-specific targeting,...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
